Nabla AI Clinches $70M to Transform Healthcare with Next-Gen Clinical AI and Adaptive Agentic Platform

Nabla AI is thrilled to announce the successful raise of $70 million in its latest funding round, marking another significant milestone in its mission to restore the human connection at the heart of healthcare. This fresh infusion of capital underscores investor confidence in Nabla’s innovative approach to clinical AI and its transformative impact on clinical and financial workflows. Since its inception, Nabla has been pioneering the development of an industry-leading AI assistant that empowers clinicians to generate high-quality notes in seconds while streamlining a host of complex workflows through ambient documentation, dictation, and real-time coding support. The company’s seamless integration with all major EHR systems, support for over 35 languages, and widespread adoption across more than 130 health systems and provider groups are a testament to its robust technology and growing trust among healthcare professionals. With this new funding, Nabla aims to accelerate the evolution of its agentic AI assistant into an Adaptive Agentic Platform—a smarter, more dynamic tool that not only assists with coding and proactive EHR actions but also extends its support to new care settings and diverse clinical roles. The company’s distinguished leadership team, spearheaded by CEO Alex LeBrun, COO Delphine Groll, and CTO Martin Raison, along with key figures such as Dr. Ed Lee, reflects a blend of clinical insight and technological expertise. Advisors like Yann LeCun and Tony Fadell further fortify Nabla’s vision of redefining clinical efficiency and patient care. This latest investment will drive continued innovation, deepen integrations, and ultimately empower clinicians by alleviating administrative burdens, allowing them to focus on what truly matters—delivering exceptional patient care.